November 13, 2022

Unlocking the Power of Sorrento: Webcast Reveals Groundbreaking Clinical Data for Improved Rheumatoid Arthritis Treatment

newscaster03 mins

Sorrento to Host Webcast on Empowering the Lymphatics Overview ATLANTA and SAN DIEGO, Nov. 13, 2022 (GLOBE NEWSWIRE) — Sofusa®, a wholly-owned division of Sorrento Therapeutics (Nasdaq: SRNE, “Sorrento”), today announced that it will host a virtual Key Opinion Leader (KOL) panel discussion titled “Empowering the Lymphatics: Unleashing the Potential of Biologics that Target the…

Read More

Calling All OLO Inc. Investors: Don’t Miss Out on Important Deadline for Securities Class Action – Get Expert Counsel from Rosen, the Skilled Investor!

newscaster03 mins

Welcome to the Rosen Law Firm Blog! Important Deadline Reminder for Olo Inc. Investors NEW YORK, Nov. 13, 2022 (GLOBE NEWSWIRE) — Here at Rosen Law Firm, we want to remind all purchasers of Olo Inc. securities between August 11, 2021 and August 11, 2022 about the upcoming deadline for the lead plaintiff in the…

Read More